Free Trial
OTCMKTS:GLAE

Imation (GLAE) Stock Price, News & Analysis

Imation logo
$30.00 0.00 (0.00%)
As of 08/8/2025

About Imation Stock (OTCMKTS:GLAE)

Key Stats

Today's Range
$30.00
$30.00
50-Day Range
$25.00
$30.00
52-Week Range
$20.00
$32.00
Volume
N/A
Average Volume
N/A
Market Capitalization
$900 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GLAE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imation and its competitors with MarketBeat's FREE daily newsletter.

GLAE Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Seafood Salad Stuffed Rainbow Peppers
See More Headlines

GLAE Stock Analysis - Frequently Asked Questions

Imation's stock was trading at $32.00 on January 1st, 2025. Since then, GLAE stock has decreased by 6.3% and is now trading at $30.00.

Imation Corporation (OTCMKTS:GLAE) posted its earnings results on Tuesday, August, 14th. The company reported ($0.39) EPS for the quarter. The firm had revenue of $8 million for the quarter.

Imation shares reverse split before market open on Wednesday, February 22nd 2017.The 1-10 reverse split was announced on Friday, February 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 21st 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of GLAE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imation investors own include Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Amira Nature Foods (ANFI), Ampliphi Biosciences (APHB) and Athersys (ATHX).

Company Calendar

Last Earnings
8/14/2018
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
FIN - MISC SVCS
Sub-Industry
Trading
Current Symbol
OTCMKTS:GLAE
Previous Symbol
NYSE:GLA
CIK
1014111
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$100 thousand
Price / Sales
9.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
30,000
Free Float
26,000
Market Cap
$900 thousand
Optionable
Not Optionable
Beta
6.27
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:GLAE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners